Novastream Therapeutics Inc. — Form D
Novastream Therapeutics Inc. of DENVER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-17. The offering totals $250K, of which $50K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-10-17
- Form: D
- Accession: 0001997658-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $250K
- Amount sold: $50K
- Remaining: $200K
- Investors: 4
- Date of first sale: 2023-10-03
- Revenue range: Not Applicable
- SEC file number: 021-495011
Issuer
- Name: Novastream Therapeutics Inc.
- CIK: 0001997658
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 5595 WASHINGTON STREET, DENVER, CO, 80216
- Phone: 720-924-9237
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Thomas Kluz | Director | Denver, CO |
| Jason Novak | Director | Denver, CO |
| Manuel Ornelas | Director | Denver, CO |
| Mark Webb | Director | Salt Lake City, UT |
| Manuel Ornelas | Executive Officer | Denver, CO |
More